Medtronic plc (MDT)

Market Cap	123.04B
Revenue (ttm)	34.20B
Net Income (ttm)	4.66B
Shares Out	1.28B
EPS (ttm)	3.62
PE Ratio	26.49
Forward PE	16.73
Dividend	$2.84 (2.96%)
Ex-Dividend Date	Sep 26, 2025

Volume	5,137,164
Open	96.09
Previous Close	95.78
Day's Range	94.93 - 96.60
52-Week Range	79.29 - 99.37
Beta	0.79
Analysts	Buy
Price Target	104.07 (+8.5%)
Earnings Date	Nov 18, 2025

About MDT

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1949
• Employees: 95,000
• Stock Exchange: NYSE
• Ticker Symbol: MDT
• Website: https://www.medtronic.com

Financial Performance

In 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.

Analyst Summary

According to 16 analysts, the average rating for MDT stock is "Buy." The 12-month stock price target is $104.07, which is an increase of 8.50% from the latest price.

Price Target

$104.07

(8.50% upside)

Analyst Consensus: Buy